TrialLeukemia & lymphoma2012

A phase 2 study of vorinostat for treatment of relapsed or refractory Hodgkin lymphoma: Southwest Oncology Group Study S0517.

Mark H Kirschbaum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.